Amphastar Pharma Q3 Adj. EPS $1.14 Beats $0.86 Estimate, Sales $207.608M Beat $197.852M Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Beats
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $0.86 by 32.56 percent. This is a 22.58 percent increase over earnings of $0.93 per share from
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $0.86 by 32.56 percent. This is a 22.58 percent increase over earnings of $0.93 per share from the same period last year. The company reported quarterly sales of $207.608 million which beat the analyst consensus estimate of $197.852 million by 4.93 percent. This is a 8.22 percent increase over sales of $191.840 million the same period last year.